TAMPA, Fla., March 10, 2016 -- Commonwealth Capital Corp., through its general partner and manager, has announced that it began issuing the Schedule K-1s for all public and private funds it manages as of February 29, 2016. K-1s have been mailed directly to all investors through Commonwealth’s transfer agent. Investors and their registered representatives may retrieve their K-1 tax information for printing or downloading via Commonwealth’s web portal.
Since its founding, Commonwealth has been committed to consistently delivering tax information to investors prior to the required due date.
Commonwealth products, both institutional and retail, invest primarily in information technology, medical technology and material handling equipment leases for Fortune 1000 and investment-grade US companies. Commonwealth uses the proceeds of their offerings, operating revenues and debt to purchase business-essential capital equipment, with a focus on technology equipment. The equipment is acquired and leased primarily through operating leases.
For more information on Commonwealth, visit their website at www.ccclease.com
Contact: Jill Swartz Spotlight Marketing Communications 949.427.5172, ext. 701 – direct [email protected]


Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
OpenAI Explores Massive Funding Round at $750 Billion Valuation
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 



